Other serious side effects may include pancreatitis, changes in vision, low blood sugar when combined with insulin or sulfonylureas, dehydration leading to kidney problems, severe gastrointestinal symptoms, gallbladder issues, and serious allergic reactions
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist with rapidly growing use, has demonstrated even greater effects on glycemic control and weight loss 13,14,15
A serious medical weight loss plan addresses muscle directly: Protein intake
designed to improve metabolism, helps lower blood sugar levels, supports liver repair , neuropathy, reduce inflammation, and detoxify free radicals that contribute to aging
Long-term shedding of SARS-CoV-2 is widely reported, even after resolution of symptomatic COVID-19
Mochi Health: Specific Patient Profiles Who Should Avoid It (and Why) At a glance Service type / GLP-1 telehealth (insurance + cash-pay) Primary medications offered / Semaglutide, tirzepatide, compounded GLP-1 agents Monthly membership fee / Approximately $99/month (as of early 2025) Insurance accepted / Yes, select plans BBB accreditation / Not accredited as of January 2025 FDA-cleared drugs available / Yes (Wegovy, Ozempic, Mounjaro, Zepbound) Key contraindicated profiles / MTC/MEN2 history, active eating disorder, pregnancy, severe renal/hepatic disease LegitScript status / Not certified as of January 2025 Prescriber type / Physician and nurse practitioner-staffed asynchronous + synchronous visits Compounded GLP-1 risk / Compounded semaglutide from 503A/503B pharmacies carries FDA safety warnings What Is Mochi Health and How Does It Work